Related Experiment Video
Updated: Jul 16, 2026
10:11
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
Anthrax vaccines: Pasteur to the present
A Scorpio1, T E Blank, W A Day
1Bacteriology Division, United States Army Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, Maryland 21701, USA.
Cellular and Molecular Life Sciences : CMLS
|September 12, 2006
Summary
Anthrax vaccines have evolved significantly since the 1800s, improving safety and efficacy. Ongoing research into Bacillus anthracis aims to discover novel vaccine targets against resistant strains.
Area of Science:
- Veterinary Medicine
- Microbiology
- Immunology
Background:
- Anthrax has historically caused significant mortality in livestock and humans.
- Extensive international efforts in anthrax vaccine development began in the late 19th century.
Observation:
- Vaccination has dramatically reduced anthrax infection rates in animals.
- Anthrax vaccines have progressed from whole-cell preparations to advanced recombinant antigens.
Findings:
- Vaccine refinements have enhanced safety without compromising efficacy.
- Genomic and proteomic approaches are identifying new targets for anthrax vaccines.
Implications:
- Future anthrax vaccines may utilize recombinant protective antigen for improved safety and efficacy.
- Research is crucial to counter the threat of antibiotic and vaccine-resistant Bacillus anthracis strains.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:25Inhalation Anthrax
Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.